AMCP Comment Letter on Health Technology Ecosystem

Topic(s):

Quality of Care , Legislation & Regulation , Coverage Parity , Drug Utilization Review (DUR)

As CMS explores strategies to increase the adoption of digital health tools, AMCP urges CMS to support broader coverage of prescription digital therapeutics (PDTs) under Medicare and Medicaid. PDTs represent an emerging class of software-based treatments that deliver clinically validated therapeutic benefits, either independently or in combination with other interventions. These products can play a transformative role in improving access, especially for patients with behavioral health conditions or chronic diseases.

View Letter